{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:35:56Z","timestamp":1761964556856},"reference-count":38,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.063","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T14:01:07Z","timestamp":1396274467000},"page":"3019-3024","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP\u2013IPV) vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Matthew F.","family":"Daley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Katherine","family":"Yih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J.","family":"Hambidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal J.","family":"Narwaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2014.03.063_bib0005","first-page":"1","article-title":"Recommended immunization schedules for persons aged 0 through 18 Years\u2014United States, 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"39","key":"10.1016\/j.vaccine.2014.03.063_bib0010","first-page":"1078","article-title":"Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"35\u201336","key":"10.1016\/j.vaccine.2014.03.063_bib0015","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1016\/j.vaccine.2006.04.001","article-title":"Immunogenicity and safety of a combined DTaP\u2013IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4\u20136 years","volume":"24","author":"Black","year":"2006","journal-title":"Vaccine"},{"issue":"35\u201336","key":"10.1016\/j.vaccine.2014.03.063_bib0020","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1016\/j.vaccine.2006.05.017","article-title":"A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4\u20136 years","volume":"24","author":"Marshall","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2014.03.063_bib0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/INF.0b013e3181616180","article-title":"Diphtheria\u2013tetanus\u2013acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4\u20136 years of age","volume":"27","author":"Black","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.03.063_bib0030","article-title":"Full prescribing information, Kinrix (Kinrix package insert) GlaxoSmithKline Biologicals","author":"GlaxoSmithKline Biologicals","year":"2012","journal-title":"Research Park Triangle, NC, Package insert date July"},{"issue":"19","key":"10.1016\/j.vaccine.2014.03.063_bib0035","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsa0806477","article-title":"Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases","volume":"360","author":"Omer","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2014.03.063_bib0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/erv.10.36","article-title":"Current controversies in the USA regarding vaccine safety","volume":"9","author":"Chatterjee","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"10 Supl 2","key":"10.1016\/j.vaccine.2014.03.063_bib0045","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45","author":"Lieu","year":"2007","journal-title":"Med Care"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2014.03.063_bib0050","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1542\/peds.2010-1722I","article-title":"Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project","volume":"127","author":"Yih","year":"2011","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2014.03.063_bib0055","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2014.03.063_bib0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/07474946.2011.539924","article-title":"A maximized sequential probability ratio test for drug and vaccine safety surveillance","volume":"30","author":"Kulldorff","year":"2011","journal-title":"Seq Anal"},{"issue":"1","key":"10.1016\/j.vaccine.2014.03.063_bib0065","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"10.1016\/j.vaccine.2014.03.063_bib0070","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.1542\/peds.106.4.e51","article-title":"Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years\u2019 data from the Vaccine Adverse Event Reporting System (VAERS)","volume":"106","author":"Braun","year":"2000","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2014.03.063_bib0075","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00006454-200208000-00016","article-title":"Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids","volume":"21","author":"Jackson","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2014.03.063_bib0080","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","article-title":"The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine","volume":"345","author":"Barlow","year":"2001","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.03.063_bib0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-510X(78)90232-0","article-title":"Relapsing neuropathy due to tetanus toxoid. Report of a case","volume":"37","author":"Pollard","year":"1978","journal-title":"J Neurol Sci"},{"issue":"20","key":"10.1016\/j.vaccine.2014.03.063_bib0090","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.1994.03510440062034","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.vaccine.2014.03.063_bib0095","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2105\/AJPH.87.12.2045","article-title":"The risk of Guillain\u2013Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States","volume":"87","author":"Tuttle","year":"1997","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2014.03.063_bib0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jpeds.2004.08.005","article-title":"Stroke after varicella vaccination","volume":"145","author":"Wirrell","year":"2004","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.vaccine.2014.03.063_bib0105","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0025-6196(11)62605-0","article-title":"Stevens\u2013Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines","volume":"79","author":"Chopra","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00006454-200102000-00022","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the Vaccine Adverse Event Reporting System","volume":"20","author":"Ball","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.03.063_bib0115","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"issue":"32","key":"10.1016\/j.vaccine.2014.03.063_bib0120","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.vaccine.2009.05.036","article-title":"An assessment of the safety of adolescent and adult tetanus\u2013diphtheria\u2013acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink","volume":"27","author":"Yih","year":"2009","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2014.03.063_bib0125","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/aje\/kws317","article-title":"Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP\u2013IPV\u2013Hib vaccine safety study","volume":"177","author":"Nelson","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"39","key":"10.1016\/j.vaccine.2014.03.063_bib0135","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1016\/j.vaccine.2009.06.092","article-title":"Predictive value of seizure ICD-9 codes for vaccine safety research","volume":"27","author":"Shui","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2014.03.063_bib0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3414\/ME0500","article-title":"Predictive value of ICD-9-CM codes used in vaccine safety research","volume":"47","author":"Mullooly","year":"2008","journal-title":"Methods Inf Med"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0038-1633855","article-title":"Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety","volume":"43","author":"Mullooly","year":"2004","journal-title":"Methods Inf Med"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1214\/aoms\/1177731118","article-title":"Sequential tests of statistical hypotheses","volume":"16","author":"Wald","year":"1945","journal-title":"Ann Math Stat"},{"issue":"1","key":"10.1016\/j.vaccine.2014.03.063_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e3181af8605","article-title":"Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine","volume":"29","author":"Belongia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project","volume":"41","author":"Lee","year":"2011","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/sim.3780","article-title":"A conditional maximized sequential probability ratio test for pharmacovigilance","volume":"29","author":"Li","year":"2010","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2014.03.063_bib0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vaccine.2012.07.024","article-title":"Biologically plausible and evidence-based risk intervals in immunization safety research","volume":"31","author":"Rowhani-Rahbar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.063_bib0175","doi-asserted-by":"crossref","DOI":"10.1002\/sim.5733","article-title":"A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design","author":"Xu","year":"2013","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0180","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-1496","article-title":"Lack of association between acellular pertussis vaccine and seizures in early childhood","volume":"126","author":"Huang","year":"2010","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2014.03.063_bib0185","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1994.tb05932.x","article-title":"The prevalence and incidence of convulsive disorders in children","volume":"35","author":"Hauser","year":"1994","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.063_bib0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/oxfordjournals.aje.a009785","article-title":"Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team","volume":"149","author":"Mullooly","year":"1999","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:15:13Z","timestamp":1648728913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14004320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":38,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14004320"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP\u2013IPV) vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}